In the intersection of the COVID-19 outbreak and marijuana businesses across the U.S., two different stories have emerged.
At the top of the pecking order, major cannabis players aren’t looking so swell. Entire growth strategies have been scrapped, thanks to disruptions in supply chains and dropping stock market valuation. Raising capital was already difficult for … Read the rest